Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients

NCT00774982 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohns Disease

Interventions

DRUG: Delayed Release 6 mercaptopurine
DRUG: 6 Mercaptopurine

Sponsor

Teva GTC